European public assessment reports

  • Email
  • Help

This page allows you to find the European public assessment reports (EPAR) for human medicines published by the European Medicines Agency (EMA).

The EMA publishes an EPAR for every medicine granted a central marketing authorisation by the European Commission following an assessment by the EMA's Committee for Medicinal Products for Human Use (CHMP). EPARs are full scientific assessment reports of medicines authorised at a European Union level. 

Use this search to find information including a public-friendly summary in question-and-answer format and the package leaflet. You can also find information on medicines that have been refused a marketing authorisation or that have been suspended or withdrawn after being approved.

As of October 2016, EMA publishes the clinical data submitted by pharmaceutical companies to support their marketing applications for human medicines under the centralised procedure, allowing the public to better understand the Agency’s decision-making. For more information see clinical data publication.

The Agency does not evaluate all medicines currently in use in Europe. If you cannot find the medicine you need through this search, please visit the website of your national health authority.

More information is available on the Central authorisation procedure and in EPARs: background and context.

Document status

Include:

Browse by letter

Browse by letter for medicines that have a European Public Assessment Report:

Or for other types of content pick from the navigation on the left.

Search by keyword

Search for keyword:

Search by therapeutic area

Browse the database based on therapeutic area:

/

Browse by type

Browse by type:

Download results to spreadsheet
EPAR Search results
Name Active substance Therapeutic area Date of authorisation / refusal Additional monitoring Orphan     Has current safety alert Status
Cometriq

cabozantinib

Thyroid Neoplasms 2014-03-21           Authorised
Fampyra

fampridine

Multiple Sclerosis 2011-07-20           Authorised
Erivedge

vismodegib

Carcinoma, Basal Cell 2013-07-12           Authorised
Epivir

lamivudine

HIV Infections 1996-08-08           Authorised
Myocet

doxorubicin hydrochloride

Breast Neoplasms 2000-07-13           Authorised
Corbilta (previously Levodopa/Carbidopa/Entacapone Sandoz)

levodopa / carbidopa / entacapone

Nervous System Diseases Neurodegenerative Diseases Parkinson Disease 2013-11-11           Authorised
Oxervate

recombinant human Nerve Growth factor (rhNGF)

Keratitis 2017-07-06           Authorised
Zutectra

human hepatitis-B immunoglobulin

Hepatitis B Immunization, Passive Liver Transplantation 2009-11-30           Authorised
NexoBrid

concentrate of proteolytic enzymes enriched in bromelain

Debridement 2012-12-18           Authorised
Memantine Accord

memantine hydrochloride

Alzheimer Disease 2013-12-04           Authorised
Pritor

telmisartan

Hypertension 1998-12-11           Authorised
Tadalafil Mylan

tadalafil

Erectile Dysfunction 2014-11-21           Authorised
Targretin

bexarotene

Lymphoma, T-Cell, Cutaneous 2001-03-29           Authorised
Eklira Genuair

aclidinium bromide, micronised

Pulmonary Disease, Chronic Obstructive 2012-07-20           Authorised
Lonquex

lipegfilgrastim

Neutropenia 2013-07-25           Authorised
Pregabalin Accord

pregabalin

Anxiety Disorders Epilepsy 2015-08-28           Authorised
Nitisinone MDK (previously Nitisinone MendeliKABS)

nitisinone

Tyrosinemias 2017-08-24           Authorised
Tasermity

sevelamer hydrochloride

Hyperphosphatemia Renal Dialysis 2015-02-26           Authorised
Pedea

ibuprofen

Ductus Arteriosus, Patent 2004-07-29           Authorised
Forsteo

teriparatide

Osteoporosis Osteoporosis, Postmenopausal 2003-06-10           Authorised
Ecalta

anidulafungin

Candidiasis 2007-09-20           Authorised
Pregabalin Sandoz

pregabalin

Anxiety Disorders Epilepsy Neuralgia 2015-06-19           Authorised
Renvela

sevelamer carbonate

Hyperphosphatemia Renal Dialysis 2009-06-10           Authorised
Daliresp

roflumilast

Pulmonary Disease, Chronic Obstructive 2011-02-28           Authorised
Renagel

sevelamer

Hyperphosphatemia Renal Dialysis 2000-01-28           Authorised